Proteomic study identified HSP 70kDa protein 1A as a possible therapeutic target, in combination with histone deacetylase inhibitors, for lymphoid neoplasms

Anticancer activities of histone deacetylase inhibitors

Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919 · see citing works

Histone deacetylases and cancer: causes and therapies

Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866 · see citing works

The role of the unfolded protein response in tumour development: friend or foe?

Ma, Y., & Hendershot, L. M. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1505 · Cited by 712 · see citing works

Molecular chaperones and the stress of oncogenesis

Mosser, D. D., & Morimoto, R. I. (2004) · Oncogene · doi:10.1038/sj.onc.1207529 · Cited by 500 · see citing works

Histone deacetylase inhibitors: discovery and development as anticancer agents

Marks, P. A., & Dokmanovic, M. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.12.1497 · Cited by 318 · see citing works

Sodium Valproate: Monotherapy and Polytherapy

Covanis, A., Gupta, A., & Jeavons, P. M. (1982) · Epilepsia · doi:10.1111/j.1528-1157.1982.tb05085.x · Cited by 285 · see citing works

Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells.

Yokota, S., Kitahara, M., & Nagata, K. (2000) · PubMed · Cited by 228 · see citing works

Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets?

Khalil, A. A., Kabapy, N. F., Deraz, S. F., & Smith, C. A. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.05.001 · Cited by 196 · see citing works

Histone Deacetylase Inhibitors in Programmed Cell Death and Cancer Therapy

Marks, P. A., & Jiang, X. (2005) · Cell Cycle · doi:10.4161/cc.4.4.1564 · Cited by 142 · see citing works

HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT

Bruzzese, F., Leone, A., Rocco, M., Carbone, C., Piro, G., Caraglia, M., Gennaro, E. D., & Budillon, A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22574 · Cited by 140 · see citing works

Plasma proteomics of lung cancer by a linkage of multi‐dimensional liquid chromatography and two‐dimensional difference gel electrophoresis

Okano, T., Kondo, T., Kakisaka, T., Fujii, K., Yamada, M., Kato, H., Nishimura, T., Gemma, A., Kudoh, S., & Hirohashi, S. (2006) · PROTEOMICS · doi:10.1002/pmic.200500883 · Cited by 139 · see citing works

Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70

Johnson, C. A., White, D. A., Lavender, J. S., O'Neill, L. P., & Turner, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107942200 · Cited by 119 · see citing works

Valproic acid induces p21 and topoisomerase-II (α/β) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines

Das, C. M., Aguilera, D. G., Vasquez, H., Prasad, P., Zhang, M., Wolff, J. E. A., & Gopalakrishnan, V. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9402-7 · Cited by 102 · see citing works

Proteomic study of human hepatocellular carcinoma using two‐dimensional difference gel electrophoresis with saturation cysteine dye

Fujii, K., Kondo, T., Yokoo, H., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200401004 · Cited by 88 · see citing works

Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial

DAUD, A. I., Dawson, J. L., DeConti, R. C., Biçaku, E., Marchion, D. C., Bastien, S., Hausheer, F. A., Lush, R. M., Neuger, A. M., Sullivan, D. M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1931 · Cited by 86 · see citing works

Synergistic Interaction between Histone Deacetylase and Topoisomerase II Inhibitors Is Mediated through Topoisomerase IIβ

Marchion, D. C., Biçaku, E., Turner, J. G., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1073 · Cited by 57 · see citing works

Histone Deacetylase Inhibitors Sensitize Human Non-small Cell Lung Cancer Cells to Ionizing Radiation Through Acetyl p53-Mediated c-myc Down-Regulation

Seo, S., Jin, H., Woo, S., Kim, Y., An, S., Lee, J. H., Hong, S., Lee, K.-H., Choe, T., & Park, I. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318220caff · Cited by 55 · see citing works

Screening for therapeutic targets of vorinostat by SILAC‐based proteomic analysis in human breast cancer cells

Zhou, Q. Y., Chaerkady, R., Shaw, P. G., Kensler, T. W., Pandey, A., & Davidson, N. E. (2010) · PROTEOMICS · doi:10.1002/pmic.200900602 · Cited by 46 · see citing works

Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells

Sanda, T., Okamoto, T., Uchida, Y., Nakagawa, H., Iida, S., Kayukawa, S., Suzuki, T., Oshizawa, T., Suzuki, T., Miyata, N., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404902 · Cited by 43 · see citing works

Synergistic effect of trichostatin A and 5‐aza‐2′‐deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: A proteomic study

Cecconi, D., Donadelli, M., Pozza, E. D., Rinalducci, S., Zolla, L., Scupoli, M. T., Righetti, P. G., Scarpa, A., & Palmieri, M. (2009) · PROTEOMICS · doi:10.1002/pmic.200701089 · Cited by 43 · see citing works

Quantitative Analysis of Histone Deacetylase-1 Selective Histone Modifications by Differential Mass Spectrometry

Lee, A. Y. H., Paweletz, C. P., Pollock, R. M., Settlage, R. E., Cruz, J. C., Secrist, J. P., Miller, T. A., Stanton, M. G., Kral, A. M., Ozerova, N. D. S., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr800510p · Cited by 42 · see citing works

Valproate and Bone Loss: iTRAQ Proteomics Show that Valproate Reduces Collagens and Osteonectin in SMA Cells

Fuller, H. R., Mân, N. T., Lam, L. T., Shamanin, V. A., Androphy, E. J., & Morris, G. E. (2010) · Journal of Proteome Research · doi:10.1021/pr1005263 · Cited by 41 · see citing works

Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas

Erlich, R. B., Rickwood, D., Coman, W. B., Saunders, N. A., & Guminski, A. D. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0747-1 · Cited by 37 · see citing works

Protein Expression in Human Non-Small Cell Lung Cancer: A Systematic Database

Bührens, R. I., Amelung, J. T., Reymond, M. A., et al. (2009) · Pathobiology · doi:10.1159/000245893 · Cited by 37 · see citing works

Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line

Yerlikaya, A. (2010) · Molecular Medicine Reports · doi:10.3892/mmr_000000262 · Cited by 33 · see citing works

Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line

Yerlikaya, A., Okur, E., Şeker, S., et al. (2010) · Molecular Medicine Reports · doi:10.3892/mmr_00000262 · Cited by 31 · see citing works

Synergism of Heat Shock Protein 90 and Histone Deacetylase Inhibitors in Synovial Sarcoma

Nguyen, A. T. A., Su, L., Campbell, B. A., et al. (2009) · Sarcoma · doi:10.1155/2009/794901 · Cited by 28 · see citing works

The Proteomic Profile of Pancreatic Cancer Cell Lines Corresponding to Carcinogenesis and Metastasis

Yamada, M., Fujii, K., Koyama, K., et al. (2009) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000057 · Cited by 26 · see citing works

Toward a comprehensive quantitative proteome database: protein expression map of lymphoid neoplasms by 2‐D DIGE and MS

Fujii, K., Kondo, T., Yamada, M., et al. (2006) · PROTEOMICS · doi:10.1002/pmic.200600097 · Cited by 24 · see citing works

Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines.

Cao, Y., Choy, E., Hornicek, F. J., et al. (2011) · PubMed · Cited by 23 · see citing works

Database of two‐dimensional polyacrylamide gel electrophoresis of proteins labeled with CyDye DIGE Fluor saturation dye

Fujii, K., Kondo, T., Yokoo, H., et al. (2006) · PROTEOMICS · doi:10.1002/pmic.200401346 · Cited by 19 · see citing works

Valproic Acid Increases the In Vitro Effects of Nitrosureas on Human Glioma Cell Lines

Ciusani, E., Balzarotti, M., Calatozzolo, C., et al. (2007) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504007783338340 · Cited by 19 · see citing works

A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells

Milli, A., Cecconi, D., Campostrini, N., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.04.022 · Cited by 17 · see citing works

Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid

Buchi, F., Pastorelli, R., Ferrari, G., Spinelli, E., Gozzini, A., Sassolini, F., Bosi, A., Tombaccini, D., & Santini, V. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.01.033 · Cited by 14 · see citing works

Proteome Expression Database of Ewing Sarcoma: a Segment of the Genome Medicine Database of Japan Proteomics

Kikuta, K., Tsunehiro, Y., Yoshida, A., et al. (2009) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000112 · Cited by 13 · see citing works

Cancer proteome-expression database: Genome Medicine Database of Japan Proteomics

Kondo, T. (2010) · Expert Review of Proteomics · doi:10.1586/epr.09.87 · Cited by 13 · see citing works

Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas

Watanabe, T. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.504710 · Cited by 12 · see citing works

Two-dimensional electrophoresis database of fluorescence-labeled proteins of colon cancer cells

Mori, Y., Kondo, T., Yamada, T., et al. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.05.024 · Cited by 7 · see citing works

Two-dimensional electrophoresis database of fluorescence-labeled proteins of colon cancer cells

森, 康. (2005) · Medical Entomology and Zoology · Cited by 6 · see citing works

Proteome Expression Database of Lung Adenocarcinoma: a segment of the Genome Medicine Database of Japan Proteomics

Kosaihira, S., Tsunehiro, Y., Tsuta, K., et al. (2009) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000106 · Cited by 5 · see citing works

Cell type-specific transcriptional programs in mouse prefrontal cortex during adolescence and addiction

Bhattacherjee, A., Djekidel, M. N., Chen, R., Chen, W., Tuesta, L. M., & Zhang, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-12054-3 · Cited by 174 · see citing works

Sustained inhibition of deacetylases is required for the antitumor activity of the histone deactylase inhibitors panobinostat and vorinostat in models of colorectal cancer

Wilson, P. M., LaBonte, M. J., Martin, S. C., Kuwahara, S. T., El-Khoueiry, A. B., Lenz, H., & Ladner, R. D. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9914-7 · Cited by 25 · see citing works

Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine

Sulochana, S. P., Devaraj, V. C., Srinivas, N. R., & Mullangi, R. (2016) · Biomedical Chromatography · doi:10.1002/bmc.3807 · Cited by 48 · see citing works

[Histone deacetylase inhibitors, vorinostat, panobinostat].

(2016) · PubMed

Supplementary Table S1 from The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects

Shahbazi, J., Liu, P. Y., Atmadibrata, B., et al. (2023) · doi:10.1158/1078-0432.22459374.v1

Supplementary Figure S3 from The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects

Shahbazi, J., Liu, P. Y., Atmadibrata, B., et al. (2023) · doi:10.1158/1078-0432.22459386